Home » Topics » BioWorld Science

BioWorld Science
RSS

Tesaro advances JASPER study of Zejula in NSCLC

Sep. 5, 2018

Oryzon Genomics identifies new lysine-specific demethylase inhibitors

Sep. 5, 2018

Galderma Research & Development discloses RORC inverse agonists

Sep. 5, 2018

FDA grants IND clearance for phase II/III study of LYS-SAF-302 for MPS IIIA

Sep. 5, 2018

Palobiofarma and Novartis patent adenosine A2A receptor antagonists

Sep. 5, 2018

National Institute of Pharmaceutical R&D divulges BTK ihibitors

Sep. 5, 2018

Development of a new PDE9A inhibitor for the treatment of CNS diseases

Sep. 5, 2018

Ossianix to use BBB delivery technology with agents from Novo Nordisk

Sep. 5, 2018

Positive results reported across multiple endpoints in ZENITH-1 trial of oral BCX-7353

Sep. 5, 2018

Nerlynx approved in Europe as extended adjuvant therapy of HER2-positive early-stage breast cancer

Sep. 5, 2018

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...